Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:2396-2401

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lai, N. C.
Right arrow Articles by Hammond, H. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lai, N. C.
Right arrow Articles by Hammond, H. K.
Related Collections
Right arrow Congestive
Right arrow Cell signalling/signal transduction
Right arrow Heart failure - basic studies
Right arrow Gene therapy

(Circulation. 2000;102:2396.)
© 2000 American Heart Association, Inc.


Basic Science Reports

Intracoronary Delivery of Adenovirus Encoding Adenylyl Cyclase VI Increases Left Ventricular Function and cAMP-Generating Capacity

N. Chin Lai, PhD; David M. Roth, PhD, MD; Mei Hua Gao, PhD; Suzanne Fine, MS; Brian P. Head, BA; Jian Zhu, BS; M. Dan McKirnan, PhD; Christopher Kwong, BS; Nancy Dalton, BA; Kazushi Urasawa, MD; David A. Roth, PhD; H. Kirk Hammond, MD

From San Diego VA Healthcare System (D.M.R., B.P.H., J.Z., C.K., H.K.H.); the Departments of Medicine (N.D., H.K.H.) and Anesthesia (D.M.R.), University of California at San Diego; the Department of Cardiovascular Medicine, Hokkaido University School of Medicine, Sapporo, Japan (K.U.); and Collateral Therapeutics, Inc, San Diego, Calif (N.C.L., M.H.G., S.F., M.D.M., D.A.R.).

Correspondence to H. Kirk Hammond, MD, VAMC-San Diego (111-A), 3350 La Jolla Village Drive, San Diego, CA 92161. E-mail khammond{at}ucsd.edu

Background—We tested the hypothesis that intracoronary injection of a recombinant adenovirus encoding adenylyl cyclase type VI (ACVI) would increase cardiac function in pigs.

Methods and Results—Left ventricular (LV) dP/dt and cardiac output in response to isoproterenol and NKH477 stimulation were assessed in normal pigs before and 12 days after intracoronary delivery of histamine followed by intracoronary delivery of an adenovirus encoding lacZ (control) or ACVI (1.4x1012 vp). Animals that had received ACVI gene transfer showed increases in peak LV dP/dt (average increase of 1267±807 mm Hg/s; P=0.0002) and cardiac output (average increase of 39±20 mL · kg-1 · min-1; P<0.0001); control animals showed no changes. Increased LV dP/dt was evident 6 days after gene transfer and persisted for at least 57 days. Basal heart rate, blood pressure, and LV dP/dt were unchanged, despite changes in cardiac responsiveness to catecholamine stimulation. Twenty-three hour ECG recordings showed no change in mean heart rate or ectopic beats and no arrhythmias. LV homogenates from animals receiving ACVI gene transfer showed increased ACVI protein content (P=0.0007) and stimulated cAMP production (P=0.0006), confirming transgene expression and function; basal LV AC activity was unchanged. Increased cAMP-generating capacity persisted for at least 18 weeks (P<0.0002).

Conclusions—Intracoronary injection of a recombinant adenovirus encoding AC provides enduring increases in cardiac function.


Key Words: receptors, adrenergic, beta • gene transfer • heart failure • histamine • myocardial contraction




This article has been cited by other articles:


Home page
Physiol. Rev.Home page
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger
Designing Heart Performance by Gene Transfer
Physiol Rev, October 1, 2008; 88(4): 1567 - 1651.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. E. Vinge, P. W. Raake, and W. J. Koch
Gene Therapy in Heart Failure
Circ. Res., June 20, 2008; 102(12): 1458 - 1470.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. A. Bundey and P. A. Insel
Adenylyl Cyclase 6 Overexpression Decreases the Permeability of Endothelial Monolayers via Preferential Enhancement of Prostacyclin Receptor Function
Mol. Pharmacol., November 1, 2006; 70(5): 1700 - 1707.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. Fischmeister, L. R.V. Castro, A. Abi-Gerges, F. Rochais, J. Jurevicius, J. Leroy, and G. Vandecasteele
Compartmentation of Cyclic Nucleotide Signaling in the Heart: The Role of Cyclic Nucleotide Phosphodiesterases
Circ. Res., October 13, 2006; 99(8): 816 - 828.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Sastry, E. Arnold, H. Gurji, A. Iwasa, H. Bui, A. Hassankhani, H. H. Patel, J. R. Feramisco, D. M. Roth, N. C. Lai, et al.
Cardiac-Directed Expression of Adenylyl Cyclase VI Facilitates Atrioventricular Nodal Conduction
J. Am. Coll. Cardiol., August 1, 2006; 48(3): 559 - 565.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Suzuki, T.-C. Lee, J. A. Fallavollita, and J. M. Canty Jr
Adenoviral Gene Transfer of FGF-5 to Hibernating Myocardium Improves Function and Stimulates Myocytes to Hypertrophy and Reenter the Cell Cycle
Circ. Res., April 15, 2005; 96(7): 767 - 775.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. H. Gao, T. Tang, T. Guo, S. Q. Sun, J. R. Feramisco, and H. K. Hammond
Adenylyl Cyclase Type VI Gene Transfer Reduces Phospholamban Expression in Cardiac Myocytes via Activating Transcription Factor 3
J. Biol. Chem., September 10, 2004; 279(37): 38797 - 38802.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. C. Lai, D. M. Roth, M. H. Gao, T. Tang, N. Dalton, Y. Y. Lai, M. Spellman, P. Clopton, and H. K. Hammond
Intracoronary Adenovirus Encoding Adenylyl Cyclase VI Increases Left Ventricular Function in Heart Failure
Circulation, July 20, 2004; 110(3): 330 - 336.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. M. Roth, N. C. Lai, M. H. Gao, J. D. Drumm, J. Jimenez, J. R. Feramisco, and H. K. Hammond
Indirect intracoronary delivery of adenovirus encoding adenylyl cyclase increases left ventricular contractile function in mice
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H172 - H177.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
F. del Monte and R. J Hajjar
Targeting calcium cycling proteins in heart failure through gene transfer
J. Physiol., January 1, 2003; 546(1): 49 - 61.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Most, A. Remppis, and H. A Katus
Conditional AC type VI expression in the heart: relevant insights into function of inducible target gene expression
Cardiovasc Res, November 1, 2002; 56(2): 181 - 183.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. H. Gao, H. Bayat, D. M Roth, J. Yao Zhou, J. Drumm, J. Burhan, and H Kirk Hammond
Controlled expression of cardiac-directed adenylylcyclase type VI provides increased contractile function
Cardiovasc Res, November 1, 2002; 56(2): 197 - 204.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. M. Feldman
Adenylyl Cyclase: A New Target for Heart Failure Therapeutics
Circulation, April 23, 2002; 105(16): 1876 - 1878.
[Full Text] [PDF]


Home page
CirculationHome page
D. M. Roth, H. Bayat, J. D. Drumm, M. H. Gao, J. S. Swaney, A. Ander, and H. K. Hammond
Adenylyl Cyclase Increases Survival in Cardiomyopathy
Circulation, April 23, 2002; 105(16): 1989 - 1994.
[Abstract] [Full Text] [PDF]